| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6121405 | Journal of Clinical Virology | 2012 | 7 Pages |
Abstract
The evaluation of HBV DNA assays should include many different genotypes. The WHO Reference Panel is universally available for manufacturers of HBV DNA assays, diagnostic laboratories and control authorities to facilitate standardized validation of HBV genotype specific detection efficiency of both diagnostic (quantitative and qualitative) and screening NAT assays.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
M. Chudy, K.-M. Hanschmann, J. Kress, S. Nick, R. Campos, U. Wend, W. Gerlich, C.M. Nübling,